Implementation facilitators and barriers to the expansion of a peer-led overdose prevention program

References

• Bowles, J. M., & Lankenau, S. E. (2019). “I gotta go with modern technology, so i'm gonna give'em the Narcan”: the diffusion of innovations and an opioid overdose prevention program. Qualitative Health Research, 29(3), 345–356.
   Google Scholar
• Bussu, S., Lalani, M., Pattison, S., & Marshall, M. (2021). Engaging with care: ethical issues in Participatory Research. Qualitative Research, 21(5), 667–685. https://doi.org/10.1177/1468794120904883
   Web of Science ®Google Scholar
• Canadian Drug Policy Coalition (CDPC). (2013). Opioid overdose prevention and response in Canada. https://drugpolicy.ca/wpcontent/uploads/2013/01/CDPC_OverdosePreventionPolicy_Final_July2014.pdf
   Google Scholar
• Cerdá, M., Gaidus, A., Keyes, K. M., Ponicki, W., Martins, S., Galea, S., & Gruenewald, P. (2017). Prescription opioid poisoning across urban and rural areas: Identifying vulnerable groups and geographic areas. Addiction (Abingdon, England), 112(1), 103–112. https://doi.org/10.1111/add.13543
   PubMed Web of Science ®Google Scholar
• Cid, A., Daskalakis, G., Grindrod, K., & Beazely, M. A. (2021). What is known about community pharmacy-based take-home naloxone programs and program interventions? A scoping review. Pharmacy, 9(1), 30. https://doi.org/10.3390/pharmacy9010030
   Web of Science ®Google Scholar
• Drainoni, M. L., Koppelman, E. A., Feldman, J. A., Walley, A. Y., Mitchell, P. M., Ellison, J., & Bernstein, E. (2016). Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment. BMS Research Notes, 9(1), 1–14. https://doi.org/10.1186/s13104-016-2268-z
   PubMedGoogle Scholar
• Dwyer, R., Fraser, S., & Dietze, P. (2016). Benefits and barriers to expanding the availability of take-home naloxone in Australia: A qualitative interview study with service providers. Drugs: Education, Prevention and Policy, 23(5), 388–396. https://doi.org/10.3109/09687637.2016.1150964
   Web of Science ®Google Scholar
• Etikan, I., Musa, S. A., & Alkassim, R. S. (2016). Comparison of convenience sampling and purposive sampling. American Journal of Theoretical and Applied Statistics, 5(1), 1–4. https://doi.org/10.11648/j.ajtas.20160501.11
   Google Scholar
• Eswaran, V., Allen, K. C., Bottari, D. C., Splawski, J. A., Bains, S., Aks, S. E., Swoboda, H. D., Moore, P. Q., Tran, T. H., Salisbury-Afshar, E., Lank, P. M., McCarthy, D. M., & Kim, H. S. (2020). Take-home naloxone program implementation: Lessons learned from seven Chicago-area hospitals. Annals of Emergency Medicine, 76(3), 318–327. https://doi.org/10.1016/j.annemergmed.2020.02.013
   PubMed Web of Science ®Google Scholar
• Ferlatte, M.-A., Milton, D., & Perreault, M. (2021). Bilan d’évaluation de la formation PROFAN 2.0 pour la période du 3 novembre 2020 au 21 mai 2021 [unpublished report], 36. p.
   Google Scholar
• Goodyear, K., & Chavanne, D. (2020). Sociodemographic characteristics and the stigmatization of prescription opioid addiction. Journal of Addiction Medicine, 14(2), 150.
   Google Scholar
• Government of Canada (2018). Drug Analysis Service: Summary report of samples analysed. Ottawa. https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/drug-analysis-service/drug-analysis-service-summary-report-samples-analysed.html
   Google Scholar
• Government of Canada (2021a). Mesures fédérales sur les opioïdes à ce jour. https://www.canada.ca/fr/sante-canada/services/opioides/mesures-federales/apercu.html
   Google Scholar
• Government of Canada (2021b). Opioid- and Stimulant-related Harms in Canada. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/#fn2-0-rf
   Google Scholar
• Guijt, I. (2014). Participatory approaches. Methodological Briefs: Impact Evaluation, 5(5), 2
   Google Scholar
• Hanson, B. L., Porter, R. R., Zöld, A. L., & Terhorst-Miller, H. (2020). Preventing opioid overdose with peer-administered naloxone: Findings from a rural state. Harm Reduction Journal, 17(1), 4–9. https://doi.org/10.1186/s12954-019-0352-0
   PubMed Web of Science ®Google Scholar
• Holland, T. J., Penm, J., Johnson, J., Sarantou, M., & Chaar, B. B. (2020). Stakeholders’ perceptions of factors influencing the use of take-home-naloxone. Pharmacy, 8(4), 232. https://doi.org/10.3390/pharmacy8040232
   Web of Science ®Google Scholar
• Institut national de santé publique du Québec. 2021. Décès reliés à une intoxication suspectée aux opioïdes ou autres drogues au Québec. https://www.inspq.qc.ca/substances-psychoactives/opioides/surdose/deces-intoxication/intoxication-suspectee
   Google Scholar
• Institut national de santé publique du Québec. 2022. Décès reliés à une intoxication suspectée aux opioïdes ou autres drogues au Québec. https://www.inspq.qc.ca/substances-psychoactives/opioides/surdose/deces-intoxication/intoxication-suspectee
   Google Scholar
• Kim, H. S., & Aks, S. E. (2022). Take-Home Naloxone and the Need for a Publicly Funded Naloxone Supply. Journal of Addiction Medicine, 16(1), 1–3. https://doi.org/10.1097/ADM.0000000000000821
   PubMed Web of Science ®Google Scholar
• Leece, P., Khorasheh, T., Paul, N., Keller-Olaman, S., Massarella, S., Caldwell, J., Parkinson, M., Strike, C., Taha, S., Penney, G., Henderson, R., & Manson, H. (2019). Communities are attempting to tackle the crisis’: A scoping review on community plans to prevent and reduce opioid-related harms. Bmj Open, 9(9), e028583. https://doi.org/10.1136/bmjopen-2018-028583
   PubMed Web of Science ®Google Scholar
• Levine, S., Medley, A., & Norton, A. (2021). Putting Indigenous harm reduction to work: Developing and evaluating “not just naloxone”. International Journal of Indigenous Health, 16(2), 244-266. https://doi.org/10.32799/ijih.v16i2.33346
   Web of Science ®Google Scholar
• MacDougall, L., Smolina, K., Otterstatter, M., Zhao, B., Chong, M., Godfrey, D., Mussavi-Rizi, A., Sutherland, J., Kuo, M., & Kendall, P. (2019). Development and characteristics of the provincial overdose cohort in British Columbia, Canada. PloS One, 14(1), e0210129. https://doi.org/10.1371/journal.pone.0210129
   PubMed Web of Science ®Google Scholar
• Martignetti, L., & Sun, W. (2022). Perspectives of stakeholders of equitable access to community naloxone programs: A literature review. Cureus, 14(1), e21461. https://doi.org/10.7759/cureus.21461
   PubMed Web of Science ®Google Scholar
• Mercer, F., Miler, J. A., Pauly, B., Carver, H., Hnízdilová, K., Foster, R., & Parkes, T. (2021). Peer support and overdose prevention responses: a systematic 'state-of-the-art’ review. International Journal of Environmental Research and Public Health, 18(22), e12073. https://doi.org/10.3390/ijerph182212073
   PubMed Web of Science ®Google Scholar
• Meza, R. D., Triplett, N. S., Woodard, G. S., Martin, P., Khairuzzaman, A. N., Jamora, G., & Dorsey, S. (2021). The relationship between first-level leadership and inner-context and implementation outcomes in behavioral health: A scoping review. Implementation Science, 16(1), 1–21. https://doi.org/10.1186/s13012-021-01104-4
   PubMed Web of Science ®Google Scholar
• Paillé, P., & Mucchielli, A. (2016). L'analyse qualitative en sciences humaines et sociales. (4th ed.). Armand Colin.
   Google Scholar
• Pauly, B., Wallace, B., Pagan, F., Phillips, J., Wilson, M., Hobbs, H., Connolly, J., & Panagiotoglou, D. (2020). Impact of overdose prevention sites during a public health emergency in Victoria, Canada. PloS One, 15(5), e0229208. https://doi.org/10.1371/journal.pone.0229208
   PubMed Web of Science ®Google Scholar
• Perreault, M., Ferlatte, M. A., Artunduaga, A., Perron, C., Tremblay, G., & Milton, D. (2021). Implantation d’un programme de prévention des surdoses géré par des pairs: l’expérience de PROFAN. Drogues, Santé Et Société, 19(1-2), 155–177. https://doi.org/10.7202/1085172ar
   Google Scholar
• Perreault, M., Ferlatte, M. A., Artunduaga, A. C., Perron, C., Marshall, C., & Milton, D. (2022). Impact of participation in a peer-led overdose program for people who use drugs. Drugs: Education, Prevention and Policy, 1–10. https://doi.org/10.1080/09687637.2022.2030302
   Web of Science ®Google Scholar
• Proctor, E. K., Landsverk, J., Aarons, G., Chambers, D., Glisson, C., & Mittman, B. (2009). Implementation research in mental health services: An emerging science with conceptual, methodological, and training challenges. Administration and Policy in Mental Health, 36(1), 24–34. https://doi.org/10.1007/s10488-008-0197-4
   PubMed Web of Science ®Google Scholar
• Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., Griffey, R., & Hensley, M. (2011). Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health, 38(2), 65–76. https://doi.org/10.1007/s10488-010-0319-7
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada (2020). Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and Stimulant-related Harms in Canada. Ottawa: Public Health Agency of Canada; December 2020. Retrieved from https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/.
   Google Scholar
• Ringwalt, C., Sanford, C., Dasgupta, N., Alexandridis, A., McCort, A., Proescholdbell, S., Sachdeva, N., & Mack, K. (2018). Community readiness to prevent opioid overdose. Health Promotion Practice, 19(5), 747–755. https://doi.org/10.1177/1524839918756887
   PubMed Web of Science ®Google Scholar
• Rudisill, T. M., Ashraf, A. J., Linn, H. I., Sayres, S., Jeffries, J. E., & Gurka, K. K. (2021). Facilitators, barriers and lessons learnt from the first state-wide naloxone distribution conducted in West Virginia. Injury Prevention : journal of the International Society for Child and Adolescent Injury Prevention, 27(4), 369–374. https://doi.org/10.1136/injuryprev-2020-043666
   PubMed Web of Science ®Google Scholar
• Salvador, J. G., Sussman, A. L., Takeda, M. Y., Katzman, W. G., Balasch, M. M., & Katzman, J. G. (2020). Barriers to and recommendations for take-home naloxone distribution: Perspectives from opioid treatment programs in New Mexico. Harm Reduction Journal, 17(1), 1–8. https://doi.org/10.1186/s12954-020-00375-2
   PubMed Web of Science ®Google Scholar
• Samuels, E. A., Baird, J., Yang, E. S., & Mello, M. J. (2019). Adoption and utilization of an emergency department naloxone distribution and peer recovery coach consultation program. Academic Emergency Medicine : official Journal of the Society for Academic Emergency Medicine, 26(2), 160–173. https://doi.org/10.1111/acem.13545
   PubMed Web of Science ®Google Scholar
• Strang, J., McDonald, R., Campbell, G., Degenhardt, L., Nielsen, S., Ritter, A., & Dale, O. (2019). Take-home naloxone for the emergency interim management of opioid overdose: The public health application of an emergency medicine. Drugs, 79(13), 1395–1418. https://doi.org/10.1007/s40265-019-01154-5
   PubMed Web of Science ®Google Scholar
• Straus, M. M., Ghitza, U. E., & Tai, B. (2013). Preventing deaths from rising opioid overdose in the US–the promise of naloxone antidote in community-based naloxone take-home programs. Substance Abuse and Rehabilitation, 2013(4), 65–72. https://doi.org/10.2147/SAR.S47463
   PubMedGoogle Scholar
• Teeter, B. S., Thannisch, M. M., Martin, B. C., Zaller, N. D., Jones, D., Mosley, C. L., & Curran, G. M. (2021). Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study. Exploratory Research in Clinical and Social Pharmacy, 2, e100019. https://doi.org/10.1016/j.rcsop.2021.100019
   PubMedGoogle Scholar
• Van Hout, M. C., & McElrath, K. (2012). Service user involvement in drug treatment programmes: Barriers to implementation and potential benefits for client recovery. Drugs: Education, Prevention and Policy, 19(6), 474–483.
   Google Scholar
• Winstanley, E. L., Clark, A., Feinberg, J., & Wilder, C. M. (2016). Barriers to implementation of opioid overdose prevention programs in Ohio. Substance Abuse, 31(1), 42–46. https://doi.org/10.1080/08897077.2015.1132294
   Google Scholar
• Wojcik, S. A. (2021). [ Including people who use drugs in the development and delivery of harm reduction programs, services, and drug policy: A scoping review of the literature ]. [Unpublished master’s thesis]. University of Victoria.
   Google Scholar
• Wood, C. A., Duello, A., Horn, P., Winograd, R., Jackson, L., Mayen, S., & Wallace, K. (2021). Overdose response training and naloxone distribution among rural first responders. Journal of Rural Mental Health, 45(3), 207–218. https://doi.org/10.1037/rmh0000166
   Google Scholar
• Young, S., Williams, S., Otterstatter, M., Lee, J., & Buxton, J. (2019). Lessons learned from ramping up a Canadian take home naloxone programme during a public health emergency: A mixed-methods study. BMJ Open, 9(10), e030046. https://doi.org/10.1136/bmjopen-2019-030046
   PubMed Web of Science ®Google Scholar